Cord blood cells aim to fix Chemo-Caused low platelets
NCT ID NCT07110090
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This early-stage trial is testing a single infusion of cells from umbilical cord blood (called XJ-MK-002) in 16 cancer patients whose platelet counts have dropped due to chemotherapy or other cancer treatments. The main goal is to see if the treatment is safe and tolerable, and to check if it can help raise platelet levels. The study is small and open-label, meaning everyone knows what they are getting, and it uses three different doses to find the safest and most promising one.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- umbilical cord blood megakaryocyte injection (XJ-MK-002)
- What this could lead to
- If it works, this could offer a new way to treat dangerously low platelet counts caused by cancer treatments, reducing the need for platelet transfusions.
- What could go wrong
- This is a very early, small Phase 1 trial with only 16 people, so it is primarily testing safety. The treatment may not raise platelets enough, and there could be side effects like allergic reactions or infection.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Cancer Hospital Chinese Academy of Medical Sciences 17 Panjiayuan Nanli, Chaoyang District
RECRUITINGBeijing, Beijing Municipality, 100021, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A good Night's sleep: could a simple program ease Cancer's toll on rest?
- Could sitting up make radiation therapy more comfortable?
- Can we predict dangerous side effects when combining radiation and immunotherapy?
- Family history as a shield: can culturally tailored guidance cut cancer risk?
- A simple screening program could transform cancer aftercare
- Can simple positive activities boost Well-Being in cancer care?